The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...

safety issues resulting from the administration of Regeneron’s Products and Regeneron’s Product Candidates (such as linvoseltamab) in patients, including serious complications or side effects ...

safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates (such as linvoseltamab) in patients, including serious complications or side effects in ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...

are associated with higher rates of side effects, such as cytokine release syndrome (CRS), and tend to need longer stays in hospital. On safety, linvoseltamab had a 100% adverse event rate ...

The jury is out on that, however, in part because the drug has been associated with side effects, particularly ... and other drugs like Regeneron’s linvoseltamab are all being tested in pivotal ...

The positive CHMP opinion is supported by data from the pivotal LINKER-MM1 trial, which evaluated linvoseltamab in adults with R/R MM. Earlier this month, the FDA accepted for review the Biologics ...

DOCTORS have issued a stark warning to those taking a common anti-acne medicine after a young man suffered a life-threatening side effect. The 20-year-old was taking isotretinoin, a controversial ...

Two Phoenix travelers' confusion over a cruise line's charges leads to On Your Side stepping in and sorting the matter out. A Mesa woman some expensive and fragile pieces of equipment and was ...

Radio host, podcaster and entrepreneur Charlamagne Tha God and iHeartMedia announced the third annual Black Effect Podcast Festival, including featured speakers at the event aimed at aspiring ...

Regeneron (REGN) announced updated data for the investigational gene therapy DB-OTO from the Phase 1/2 CHORD trial in 12 children who have profound genetic hearing loss due to variants of the ...